New Oral Anticoagulants: New Patient Safety Challenges
Dr. Alan Jacobson is a pioneer and leader in the field of anticoagulation management, having implemented innovative strategies within the VA system to improve anticoagulation management and dramatically reducing risk with out-of-range INR and complications associated with anticoagulation therapy.
Dr. Jacobson will address the challenges associated with the new therapeutic drugs, which require less monitoring, but bring new risks. There are new lessons being learned that can help keep patients safer when these innovative new medications are being used.
Following his presentation, a reactor panel will discuss the new information shared by Dr. Jacobson.
Click here to download the combined speakers' slide set in PDF format one (1) slide per page.
Click here to download the combined speakers' slide set in PDF format four (4) slides per page.
To view the file, click the desired link (please note: the files may take several minutes to download). To save to your hard drive, right click on the link and choose "Save Target As." (In some browsers it might say "Save Link As.")
The slide set could take several minutes to download. The "four per page" slide set may download more efficiently.
Registration Information and CE Credit Information:
Registration is closed for the 'live' online version of this webinar. You can view the entire webinar by watching the video above.
When:June 16, 2016 Time: 1:00 p.m.-2:30 p.m. ET
We are accepting questions now that relate to the session topics. Please e-mail any questions related to the specific session to firstname.lastname@example.org with the session title in the e-mail message header.
Need technical assistance with registration? Call 512-457-7605 between 9:00 a.m. and 4:30 p.m. CT.
Awareness: Participants will understand and be able to communicate the new frequency, severity, and preventability of errors, harm, and harm due to errors in the use of the novel anticoagulation medications.
Accountability: Participants will understand who is accountable for new behaviors to protect patients and caregivers from errors and harm with novel anticoagulation medication use.
Ability: Participants will learn the principles of importance in education, and how to enable key actors to reduce errors and harm with novel agent anticoagulation medication use.
Action: Participants will learn what direct line-of-sight actions must be taken to prevent and reduce the harm of novel agent anticoagulation medication-related adverse drug events.
CE Participation Documentation
Texas Medical Institute of Technology, approved by the California Board of Registered Nursing, Provider Number 15996, will be issuing 1.5 contact hours for this webinar. TMIT is only providing nursing credit at this time.
To request a Participation Document, please click here.
Introduction and Moderator
Charles R. Denham, MD In the News and Recent Polling Responses
During Dr. Denham's business development career spanning 30 years, he and his organizations have served hundreds of innovation teams. While in practice as a radiation oncologist, he taught biomedical engineering and product development. He has taught innovation adoption, technology transfer, and commercialization in both academia and industry. He has been an adjunct Professor of Health Services Engineering at the...
Alan K. Jacobson, MD, FACC New Oral Anticoagulants: New Patient Safety Challenges
Alan K. Jacobson, MD, FACC, is a staff cardiologist and the Associate Chief of Staff for Research at the Loma Linda VA Medical Center in Southern California. A native of Canada, Dr. Jacobson has been at Loma Linda since heading south in 1977 for medical school. In addition to practicing general cardiology, Dr. Jacobson has a special interest in antithrombotic therapy.
Jennifer Dingman Discussion and Reaction to Presentations AND The Voice of the Patient and Family
Jennifer Dingman realized, after her mother's death in 1995 due to errors in medical diagnoses and treatment, that there is little to no help available for patients and their families in similar situations. This life-changing experience left her feeling vulnerable, and she decided to dedicate her life to help prevent medical tragedies from happening to others.
U.S. Department of Health and Human Services, Office of Disease Prevention and Health Promotion. National Action Plan for Adverse Drug Event Prevention. Washington, DC: U.S. Department of Health and human Services; 2014. Available at http://www.health.gov/hai/pdfs/ADE-Action-Plan-508c.pdf.